Impact of the COVID-19 Pandemic on Risk of Sarcopenia: From Lockdown and Infection Perspectives: A Systematic Review and Meta-analysis

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2024 Aug 9

PMID 39121262

Authors

Xiang Wang

Qiaofeng Guo

Kai Huang

Gouping Ma

LiFeng Zhai

Bingyuan Lin

Haiyong Ren

Ze Yang

Affiliations

Soon will be listed here.

Abstract

Background: During the new coronavirus disease 2019 (COVID-19) pandemic, there are numerous symptoms in the skeletal muscular system, such as decreased skeletal muscle mass, strength, and muscle function, which are the main manifestations of sarcopenia. To investigate the impact of the COVID-19 pandemic on sarcopenia from the perspectives of COVID-19 pandemic lockdown and COVID-19 infection, we conducted this study.

Methods: We searched for literature related to COVID-19 and sarcopenia published in PubMed, Embase, Cochrane Library, and Web of Science. Two researchers independently searched and screened the articles, extracted data, and assessed the quality of the final included literature. RevMan 5.4 was used for meta-analysis.

Results: A total of 8 articles with a total of 1145 patients were included. There was a significant difference in SARC-F scores (MD = 0.67, 95%CI = [0.41, 0.93], Z = 5.00, P < .00001), handgrip (MD = -1.57, 95%CI = [-2.41, -0.73], Z = 3.66, P = .0002), body weight (MD = -1.87, 95%CI = [-3.69, -0.05], Z = 2.01, P = .04), and skeletal muscle mass index (MD = -0.28, 95%CI = [-0.54, -0.02], Z = 2.13, P = .03) between the time before the COVID-19 pandemic and during the COVID-19 pandemic. However, the results showed that there was no significant difference in muscle mass between the 2 groups (MD = -1.72, 95%CI = [-4.39, 0.94], Z = 1.27, P = .21).

Conclusion: The COVID-19 pandemic has had an impact on sarcopenia. Both infection with COVID-19 and lockdown during the COVID-19 pandemic increase the risk of sarcopenia. Research should pay more attention to this disease during the COVID-19 pandemic and adopt effective interventions to minimize adverse outcomes.

References

Narumi T, Watanabe T, Kadowaki S, Takahashi T, Yokoyama M, Kinoshita D . Sarcopenia evaluated by fat-free mass index is an important prognostic factor in patients with chronic heart failure. Eur J Intern Med. 2015; 26(2):118-22. DOI: 10.1016/j.ejim.2015.01.008. View

Abdelbasset W, Nambi G, Eid M, Elkholi S . Physical activity and mental well-being during COVID-19 pandemic. World J Psychiatry. 2022; 11(12):1267-1273. PMC: 8717035. DOI: 10.5498/wjp.v11.i12.1267. View

Hasegawa Y, Takahashi F, Hashimoto Y, Munekawa C, Hosomi Y, Okamura T . Effect of COVID-19 Pandemic on the Change in Skeletal Muscle Mass in Older Patients with Type 2 Diabetes: A Retrospective Cohort Study. Int J Environ Res Public Health. 2021; 18(8). PMC: 8071268. DOI: 10.3390/ijerph18084188. View

da Rocha A, Lobo P, Pimentel G . Muscle Function Loss and Gain of Body Weight during the COVID-19 Pandemic in Elderly Women: Effects of One Year of Lockdown. J Nutr Health Aging. 2021; 25(8):1028-1029. PMC: 8322632. DOI: 10.1007/s12603-021-1663-x. View

Zeigler Z . COVID-19 Self-quarantine and Weight Gain Risk Factors in Adults. Curr Obes Rep. 2021; 10(3):423-433. PMC: 8273568. DOI: 10.1007/s13679-021-00449-7. View

Tsai P, Lai W, Lin Y, Luo Y, Lin Y, Chen H . Clinical manifestation and disease progression in COVID-19 infection. J Chin Med Assoc. 2020; 84(1):3-8. DOI: 10.1097/JCMA.0000000000000463. View

Di Renzo L, Gualtieri P, Pivari F, Soldati L, Attina A, Cinelli G . Eating habits and lifestyle changes during COVID-19 lockdown: an Italian survey. J Transl Med. 2020; 18(1):229. PMC: 7278251. DOI: 10.1186/s12967-020-02399-5. View

Bhutani S, VanDellen M, Cooper J . Longitudinal Weight Gain and Related Risk Behaviors during the COVID-19 Pandemic in Adults in the US. Nutrients. 2021; 13(2). PMC: 7922943. DOI: 10.3390/nu13020671. View

Ali A, Kunugi H . Skeletal Muscle Damage in COVID-19: A Call for Action. Medicina (Kaunas). 2021; 57(4). PMC: 8069858. DOI: 10.3390/medicina57040372. View

10.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223):507-513. PMC: 7135076. DOI: 10.1016/S0140-6736(20)30211-7. View

11.

Harapan B, Yoo H . Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). J Neurol. 2021; 268(9):3059-3071. PMC: 7826147. DOI: 10.1007/s00415-021-10406-y. View

12.

Chung M, Zidar D, Bristow M, Cameron S, Chan T, Harding 3rd C . COVID-19 and Cardiovascular Disease: From Bench to Bedside. Circ Res. 2021; 128(8):1214-1236. PMC: 8048382. DOI: 10.1161/CIRCRESAHA.121.317997. View

13.

Li X, Ma X . Acute respiratory failure in COVID-19: is it "typical" ARDS?. Crit Care. 2020; 24(1):198. PMC: 7202792. DOI: 10.1186/s13054-020-02911-9. View

14.

Yamada K, Yamaguchi S, Sato K, Fuji T, Ohe T . The COVID-19 outbreak limits physical activities and increases sedentary behavior: A possible secondary public health crisis for the elderly. J Orthop Sci. 2020; 25(6):1093-1094. PMC: 7472964. DOI: 10.1016/j.jos.2020.08.004. View

15.

Papaemmanouil A, Bakaloudi D, Gkantali K, Kalopitas G, Metallidis S, Germanidis G . Phase Angle and Handgrip Strength as Predictors of Clinical Outcomes in Hospitalized COVID-19 Patients. Nutrients. 2023; 15(6). PMC: 10057973. DOI: 10.3390/nu15061409. View

16.

Beghi E, Giussani G, Westenberg E, Allegri R, Garcia-Azorin D, Guekht A . Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions. J Neurol. 2021; 269(5):2265-2274. PMC: 8528941. DOI: 10.1007/s00415-021-10848-4. View

17.

Cao T, Zhang G, Pellegrini E, Zhao Q, Li J, Luo L . COVID-19 and its effects on the digestive system. World J Gastroenterol. 2021; 27(24):3502-3515. PMC: 8240057. DOI: 10.3748/wjg.v27.i24.3502. View

18.

Ferrandi P, Alway S, Mohamed J . The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies. J Appl Physiol (1985). 2020; 129(4):864-867. PMC: 7832004. DOI: 10.1152/japplphysiol.00321.2020. View

19.

DeFronzo R, Tripathy D . Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care. 2009; 32 Suppl 2:S157-63. PMC: 2811436. DOI: 10.2337/dc09-S302. View

20.

Pinto F, Andrade M, da Silva G, Faiad J, Barrere A, Goncalves R . Function Over Mass: A Meta-Analysis on the Importance of Skeletal Muscle Quality in COVID-19 Patients. Front Nutr. 2022; 9:837719. PMC: 9067541. DOI: 10.3389/fnut.2022.837719. View